News

The new contract will facilitate Regency’s expanded use of our Roma3 pulsed electromagnetic field (PEMF) device for the treatment of chronic wounds. Under the terms of the agreement,

In addition to Channel Medical Partners, other investors include Lincoln Funds International and existing investors Canadian Medical Discoveries Fund and Morningside Technology Ventures. In conjunction with this financing,

Genedata said that it will create a global scientific computing infrastructure for the lead discovery and drug research programs at Nycomed sites worldwide. Genedata Screener is expected to

With the growth of the company and the range of target opportunities for NovaBay’s product candidates, the company said that its board has decided to separate the roles

The manufacturing permit enables the facility to manufacture in vitro diagnostic tests for the domestic Chinese market once specific product approval is received. The permit is required before

Under the terms of the agreement, Standard Chemical & Pharmaceutical has the exclusive development and manufacturing rights and Cypress Pharmaceutical has exclusive US marketing rights of the generic

According to Competitive Technologies, Early Breastest, a non-invasive technology, generates an analysis that detects angiogenesis, an early predictor of the possibility of cancer. The agreement provides for sharing

Scheduled to open during the first quarter of 2008, Mannatech Swiss International is expected to help Mannatech strengthen its competitive position in Europe, Asia and other non-North American

The partnership will focus on total spend management solutions that provide savings opportunities on consumable supplies and purchased services. In addition, the agreement will result in the implementation